« The 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome: Implications for the Inclusion of Participants in Research vs Diagnosis in Clinical Practice », Can Rheumatol Today, vol. 1, nᵒ 3, p. 20–25, déc. 2024, doi: 10.58931/crt.2024.1355.